Acute Kidney Injury in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: Pathophysiologies, Risk Factors, and Preventive Measures

• Published in: Cardiology Vol. 146; no. 6; p. 678
• Main Authors: Zhang, Ya-Feng, Liu, Da-Dong, Zhou, Yue, Lou, Ji-Zhuang
• Format: Journal Article
• Language: English
• Published: Switzerland 01.12.2021
• Subjects: Acute Coronary Syndrome - therapy; Acute Kidney Injury - etiology; Acute Kidney Injury - prevention & control; Humans; Percutaneous Coronary Intervention - adverse effects; Risk Factors; Acute coronary syndrome; Acute kidney injury; Percutaneous coronary intervention
• ISSN: 1421-9751
• DOI: 10.1159/000517991

Percutaneous coronary intervention (PCI) has been an effective treatment for acute coronary syndrome (ACS) patients. Acute kidney injury (AKI) is one of the common complications after PCI, which seriously affects the living quality and survival time of patients. The approach followed for the patient with AKI after PCI depends on the clinical context and may vary by resource availability. This review focuses on the pathophysiologies, influencing factors, and preventive measures of AKI in patients with ACS after PCI. The knowledge may better serve the patients and improve their outcomes. Key Messages: Many studies have been carried out for the definition and standard of AKI in the past few years. Etiologies of AKI after PCI included renal damage of contrast medium and atherosclerotic embolism, cardiac insufficiency and surgical factors on renal function. Basic conditions, treatment modalities, and perioperative changes are major risk factors of AKI. Studies have reported that the prevention of contrast-induced nephropathy, modulating the volume overload, some pharmaceuticals and blood purification treatment are helpful to prevent the occurrence of AKI.